Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medtronic has received approval from the FDA for the Talent thoracic stent graft, a medical device that is expected to allow more patients to benefit from a minimally invasive treatment for certain types of aneurysms of the descending thoracic aorta.
Subscribe to our email newsletter
According to Medtronic, its Talent thoracic stent graft system makes thoracic endovascular aortic repair accessible to an additional 25% of patients, because of its unique features. It is available in the widest range of diameters – from 22mm to 46mm, the company said. This size matrix offers physicians multiple options to customize devices for their patients’ needs and to treat a wider range of anatomies than with the other available endografts, claims the company.
Ronald Fairman, professor of surgery at the University of Pennsylvania Hospital, said: “FDA approval of the Talent thoracic stent graft is an important development in physicians’ abilities to treat this life-threatening condition. In my own experience, this device offers a superior alternative to open surgery and will allow physicians to perform minimally invasive thoracic aortic aneurysm repair for a broader population of patients.”